Pure Global

MAGLUMI Direct Renin - India CDSCO Medical Device Registration

MAGLUMI Direct Renin is a medical device registered with India's Central Drugs Standard Control Organization (CDSCO) under UID IMP/IVD/2020/000060_fa3d76b43503c8f04968674c28245954_0d3f82e57d1c251bfeaf819983da0165. This device is marketed under the brand name CLIA. The license holder is M/s. Golden Harvest Industries, and it is classified as Device Class Class B. The approving authority is CDSCO.

This page provides comprehensive regulatory information including complete registration details, license holder information, device classification, and related products. Pure Global AI offers free access to 71,807+ India medical device registrations, helping global MedTech companies identify partners, analyze markets, and discover business opportunities efficiently.

Free Database
Powered by Pure Global AI
CDSCO Registered
Class Class B
MAGLUMI Direct Renin
UID: IMP/IVD/2020/000060_fa3d76b43503c8f04968674c28245954_0d3f82e57d1c251bfeaf819983da0165

Brand Name

CLIA

Device Class

Class B

Approving Authority

CDSCO

Product Information

The kit is an in vitro chemiluminescent immunoassay for the quantitative determination of Renin in human EDTA-plasma specimens using the MAGLUMI series Fully-auto chemiluminescence immunoassay analyzer (CLIA)

Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing